Highlights

Highlights

  • 04.06.2026 – 07:10

    Hostpoint AG

    Hostpoint AG: The Swiss alternative to WeTransfer: Hostpoint sets new standards for file transfer services with File Express

    The Swiss alternative to WeTransfer: Hostpoint sets new standards for file transfer services with File Express

    Rapperswil-Jona (ots) - While two-thirds of Swiss people use file-sharing platforms, they would like additional security features and more useful functionality. Hostpoint is now launching a state-of-the art platform that meets all of these needs: File Express. Its features include data transmitted exclusively via Swiss servers, comprehensive transfer management and end-to-end encryption. Whether it’s contracts, business documents or vacation photos – digital file sharing is now the norm. However, it’s not always easy to send and receive files efficiently and securely, especially when ...

Actualités

Filtre
  • 24.01.2019 – 15:07

    TetraPak

    New Tetra Pak CEO Appointed

    Pully, Switzerland (ots/PRNewswire) - The Tetra Laval Group Board has appointed Mr Adolfo Orive, President & CEO of Tetra Pak effective April 1, 2019. The appointment follows the decision by Mr Dennis Jönsson to step down from his position after 14 years as President & CEO and 36 years with the company. (Logo: https://mma.prnewswire.com/media/813029/Tetra_Laval_Logo.jpg ) (Photo: https://mma.prnewswire.com/media/813041/Tetra_Pak_Adolfo_Orive.jpg ) Adolfo Orive, presently ...

  • 24.01.2019 – 14:01

    Merck Healthcare Germany

    Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors

    Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...

  • 23.01.2019 – 16:02

    Philogen

    Philogen Announces Collaboration With Celgene

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Celgene, to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Celgene, a leader in the discovery and development ...

  • 23.01.2019 – 16:01

    Philogen

    Philogen Announces Collaboration

    Siena, Italy (ots/PRNewswire) - Philogen S.p.A. (a privately-owned company) today announced that they have entered into a collaboration and license agreement with Novartis to discover and develop a new class of immunomodulatory therapeutics. (Logo: https://mma.prnewswire.com/media/811555/Philogen_Logo.jpg ) "We are extremely pleased to establish a new collaboration with Novartis, a leader in the discovery and development of therapies for cancer patients," commented Dr. ...

  • 23.01.2019 – 15:34

    Schweizerischer Nationalfonds / Fonds national suisse

    Young adults caught in a dilemma between traditional family models and modern views

    Bern (ots) - A study funded by the Swiss National Science Foundation has found that even young adults who do not yet have children are influenced by traditional concepts of family. At the same time, they have modern views of equality, career engagement and childcare. The result is a dilemma that affects not only young women, but also young men early in adulthood. ...